BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 26124638)

  • 1. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.
    Hu X; Li X; Valverde K; Fu X; Noguchi C; Qiu Y; Huang S
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10141-6. PubMed ID: 19497860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
    Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells.
    Liu L; Souto J; Liao W; Jiang Y; Li Y; Nishinakamura R; Huang S; Rosengart T; Yang VW; Schuster M; Ma Y; Yang J
    J Biol Chem; 2013 Nov; 288(48):34719-28. PubMed ID: 24163373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Determinants of Erythropoiesis: Role of the Histone Methyltransferase SetD8 in Promoting Erythroid Cell Maturation and Survival.
    DeVilbiss AW; Sanalkumar R; Hall BD; Katsumura KR; de Andrade IF; Bresnick EH
    Mol Cell Biol; 2015 Jun; 35(12):2073-87. PubMed ID: 25855754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation.
    Suzuki M; Kobayashi-Osaki M; Tsutsumi S; Pan X; Ohmori S; Takai J; Moriguchi T; Ohneda O; Ohneda K; Shimizu R; Kanki Y; Kodama T; Aburatani H; Yamamoto M
    Genes Cells; 2013 Nov; 18(11):921-33. PubMed ID: 23911012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
    Rogers H; Wang L; Yu X; Alnaeeli M; Cui K; Zhao K; Bieker JJ; Prchal J; Huang S; Weksler B; Noguchi CT
    J Biol Chem; 2012 Oct; 287(44):36720-31. PubMed ID: 22982397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells.
    Laurent B; Randrianarison-Huetz V; Kadri Z; Roméo PH; Porteu F; Duménil D
    Stem Cells; 2009 Sep; 27(9):2153-62. PubMed ID: 19522008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSD1 Mediates Neuronal Differentiation of Human Fetal Neural Stem Cells by Controlling the Expression of a Novel Target Gene, HEYL.
    Hirano K; Namihira M
    Stem Cells; 2016 Jul; 34(7):1872-82. PubMed ID: 27018646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
    Karacay B; Chang LS
    Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the role of LMO2 in human erythroid cells.
    Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
    Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
    PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD1 collaborates with EZH2 to regulate expression of interferon-stimulated genes.
    Jin Y; Huo B; Fu X; Hao T; Zhang Y; Guo Y; Hu X
    Biomed Pharmacother; 2017 Apr; 88():728-737. PubMed ID: 28152483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA2 regulates GATA1 expression through LSD1-mediated histone modification.
    Guo Y; Fu X; Huo B; Wang Y; Sun J; Meng L; Hao T; Zhao ZJ; Hu X
    Am J Transl Res; 2016; 8(5):2265-74. PubMed ID: 27347333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.